본문 바로가기

Clinical, serological and haemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicentre retrospective study from Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
RHEUMATOLOGY65(4) · 2026
피인용
Web of Science 1Scopus 1
FWCI (Scopus)
0
JCR IF
JCR 2024 4.4
ISSN
1462-0324

저자

  1. Kang, Ji-Hyoun제1저자Chonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
  2. Yoon, JiyeolYonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
  3. Song, Jason JungsikYonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
  4. Choi, Hyo-JinGachon Univ Gil Hosp, Dept Rheumatol, Incheon, South Korea
  5. Hong, SeokchanUniv Ulsan, Asan Med Ctr, Dept Internal Med, Div Rheumatol,Coll Med, Seoul, South Korea
  6. Jeon, Chan HongSoonchunhyang Univ Bucheon Hosp, Dept Internal Med, Div Rheumatol, Bucheon, South Korea
  7. 이승근Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Div Rheumatol,Sch Med, Busan, South Korea
  8. Lee, Eun BongSeoul Natl Univ, Dept Internal Med, Div Rheumatol, Coll Med, Seoul, South Korea
  9. Kim, Sang-HyonKeimyung Univ, Dept Internal Med, Div Rheumatol, Sch Med, Daegu, South Korea
  10. Choi, Sung-EunChonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
  11. Park, Dong-JinChonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
  12. Lee, Shin-Seok교신저자Chonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea

초록

Objective: To identify factors associated with adverse outcomes in Korean patients with systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-PAH) confirmed by right heart catheterization (RHC). Methods: This multicentre retrospective study included 68 patients with SLE-PAH diagnosed by RHC at eight tertiary centres. Baseline demographic, clinical, laboratory and haemodynamic data were collected, along with SLE Disease Activity Index (SLEDAI) scores and PAH-related parameters. Primary endpoint was a composite outcome of worsening PAH symptoms requiring treatment escalation, lung transplantation, death or hospitalization. Univariable and multivariable logistic regression analyses were performed to identify independent predictors. Results: Of 68 patients, 35 (51.3%) experienced composite outcomes. Compared with those without composite outcomes, patients with composite outcomes had significantly shorter baseline 6-min walk distances (P = 0.024), higher tricuspid regurgitation velocity (P = 0.032), higher right ventricular systolic pressure (P = 0.035), higher mean pulmonary arterial pressure (mPAP) (P < 0.001), higher mean physician global assessment scores (P = 0.001), higher mean SLEDAI scores (P = 0.005) and more frequent use of combination PAH therapy (P = 0.033). In multivariable analysis, elevated mPAP (odds ratio (OR) 5.401; 95% confidence interval (CI) 1.129–25.837, P = 0.035), higher SLEDAI (OR 5.495; 95% CI 1.041–29.012, P = 0.045) and combination PAH therapy (OR 1.695; 95% CI 1.015–3.267, P = 0.017) remained independent predictors of composite outcomes. Conclusions: Elevated mPAP, active lupus and use of combination PAH therapy were independently associated with poor outcomes in SLE-PAH, highlighting the relevance of comprehensive haemodynamic assessment and careful management of lupus activity.

키워드

catheterizationpulmonary arterial hypertensionright heart systemsystemic lupus erythematosus

식별자

Scopus EID
2-s2.0-105035442789
WoS UID
001735324400001